Liver stem cell

Patent Number: 6872389

This patent covers a liver stem cell that is isolated based on expression of the marker OV6. These cells could be used for a variety of therapeutic purposes including hepatitis. Liver cell therapy can be performed by administration of single cell suspensions, additionally attractive with this patent is that liver cells are generally more tolerogenic and less likely to rejection than other tissues. Accordingly, it may be possible to use allogeneic cadaver liver cells for practicing this patent...or alteratively if liver cell lines may be made, an "off the shelf" product may be generated.

View this patent on the USPTO website.